Forebygging av legemiddel-indusert anemi eller trombocytopeni

Patent ductus arteriosus, low platelets, cyclooxygenase inhibitors, and intraventricular hemorrhage in very low birth weight preterm infants. (åpner nytt vindu)

Brunner B, Hoeck M, Schermer E, Streif W, Kiechl-Kohlendorfer U.

Kilde‎: J Pediatr 2013;163(1):23-8.

Arkiv‎: PubMed 23351600

DOI‎: 10.1016/j.jpeds.2012.12.035

https://www.ncbi.nlm.nih.gov/pubmed/23351600 (åpner nytt vindu)

Natalizumab use during the third trimester of pregnancy. (åpner nytt vindu)

Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, Kümpfel T, Meinl I, Plavina T, Gold R, Hellwig K.

Kilde‎: JAMA Neurol 2014;71(7):891-5.

Arkiv‎: PubMed 24821217

DOI‎: 10.1001/jamaneurol.2014.209

https://www.ncbi.nlm.nih.gov/pubmed/24821217 (åpner nytt vindu)

Hemolytic anemia and methemoglobinemia in a preterm baby as a complication of antenatal intraamnial injection of toluidine blue. (åpner nytt vindu)

Mehler K, Oberthuer A, Weisshaar G, Valter M, Vierzig A, Eifinger F.

Kilde‎: Klin Padiatr 2013;225(5):263-5.

Arkiv‎: PubMed 23519748

DOI‎: 10.1055/s-0033-1333756

https://www.ncbi.nlm.nih.gov/pubmed/23519748 (åpner nytt vindu)

Drug-induced thrombocytopenia in children. (åpner nytt vindu)

Reese JA, Nguyen LP, Buchanan GR, Curtis BR, Terrell DR, Vesely SK, George JN.

Kilde‎: Pediatr Blood Cancer 2013;60(12):1975-81.

Arkiv‎: PubMed 24038783

DOI‎: 10.1002/pbc.24682

https://www.ncbi.nlm.nih.gov/pubmed/24038783 (åpner nytt vindu)

NEONATAL MEDISIN

Forebygging av legemiddel-indusert anemi eller trombocytopeni

Norsk

Forebygging av legemiddel-indusert anemi eller trombocytopeni

https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

Forebygging av legemiddel-indusert anemi eller trombocytopeni

Patent ductus arteriosus, low platelets, cyclooxygenase inhibitors, and intraventricular hemorrhage in very low birth weight preterm infants. (åpner nytt vindu)

Natalizumab use during the third trimester of pregnancy. (åpner nytt vindu)

Hemolytic anemia and methemoglobinemia in a preterm baby as a complication of antenatal intraamnial injection of toluidine blue. (åpner nytt vindu)

Drug-induced thrombocytopenia in children. (åpner nytt vindu)

Sykehuskontaktutvalg (SKU)

Medisinsk informasjonsmateriale

Videoer

Forebygging av legemiddel-indusert anemi eller trombocytopeni

Patent ductus arteriosus, low platelets, cyclooxygenase inhibitors, and intraventricular hemorrhage in very low birth weight preterm infants. (åpner nytt vindu)

Natalizumab use during the third trimester of pregnancy. (åpner nytt vindu)

Hemolytic anemia and methemoglobinemia in a preterm baby as a complication of antenatal intraamnial injection of toluidine blue. (åpner nytt vindu)

Drug-induced thrombocytopenia in children. (åpner nytt vindu)

Sykehuskontaktutvalg (SKU)

Medisinsk informasjonsmateriale

Videoer

Velg ditt språk

Del